TOCILIZUMAB-AAZG

TOCILIZUMAB-AAZG was reported 616 times

TOCILIZUMAB-AAZG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUBACUTE PANCREATITIS 1 0.1429
1 RHEUMATOID NODULE REMOVAL 2 0.0833
2 CHOLESTEATOMA 15 0.0538
3 VACCINATION SITE INDURATION 1 0.0294
4 HAEMORRHAGIC URTICARIA 1 0.0250
5 IMMUNE-MEDIATED PANCYTOPENIA 1 0.0204
6 PULMONARY PNEUMATOCELE 1 0.0141
7 GASTROENTERITIS ASTROVIRAL 1 0.0125
8 ADMINISTRATION SITE OEDEMA 1 0.0116
9 ADMINISTRATION SITE PRURITUS 1 0.0078
10 LARYNGEAL DYSKINESIA 1 0.0078
11 HYPERFERRITINAEMIA 3 0.0070
12 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 1 0.0057
13 ACETABULUM FRACTURE 2 0.0053
14 BREAST NECROSIS 1 0.0048
15 EOSINOPHILIC CELLULITIS 1 0.0047
16 HERPES ZOSTER CUTANEOUS DISSEMINATED 1 0.0043
17 TONGUE GEOGRAPHIC 1 0.0040
18 CHONDROMALACIA 1 0.0035
19 GASTROENTERITIS ROTAVIRUS 1 0.0032
20 GENERALISED BULLOUS FIXED DRUG ERUPTION 1 0.0027
21 LIPID METABOLISM DISORDER 1 0.0026
22 VESTIBULAR DISORDER 3 0.0024
23 LEUKOCYTURIA 2 0.0024
24 INVASIVE BREAST CARCINOMA 1 0.0024
25 GIANT CELL ARTERITIS 2 0.0024
26 ALLERGY TEST POSITIVE 1 0.0022
27 ANAPHYLACTOID REACTION 9 0.0022
28 INFUSION SITE VESICLES 1 0.0019
29 URTICARIAL VASCULITIS 1 0.0019
30 STEATOHEPATITIS 1 0.0019
31 BURNING MOUTH SYNDROME 1 0.0018
32 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
33 BLOOD PRESSURE DIASTOLIC ABNORMAL 4 0.0016
34 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
35 CHORIORETINITIS 1 0.0016
36 INFUSION SITE INFLAMMATION 1 0.0014
37 POLYMYALGIA RHEUMATICA 4 0.0013
38 DYSCHROMATOPSIA 1 0.0012
39 LUNG OPERATION 1 0.0012
40 LIP PRURITUS 1 0.0012
41 ADENOMA BENIGN 1 0.0012
42 RHEUMATOID NODULE 3 0.0011
43 BONE CYST 1 0.0011
44 DUODENAL PERFORATION 1 0.0010
45 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
46 HYPOFIBRINOGENAEMIA 1 0.0010
47 CARPAL TUNNEL DECOMPRESSION 1 0.0009
48 CUSHINGOID 3 0.0009
49 DIABETIC NEPHROPATHY 2 0.0009
50 FACIAL SPASM 1 0.0009
51 HYPERSENSITIVITY PNEUMONITIS 1 0.0009
52 LICHENOID KERATOSIS 2 0.0009
53 ADMINISTRATION SITE PAIN 1 0.0009
54 FOLATE DEFICIENCY 1 0.0009
55 LABILE BLOOD PRESSURE 1 0.0008
56 OXYGEN CONSUMPTION INCREASED 2 0.0008
57 BREATH ODOUR 2 0.0008
58 RETINAL DEGENERATION 1 0.0008
59 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
60 PHARYNGEAL ULCERATION 1 0.0008
61 PLASMA CELL MYELOMA REFRACTORY 1 0.0007
62 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
63 CONJUNCTIVITIS ALLERGIC 1 0.0007
64 MIXED LIVER INJURY 2 0.0007
65 DEVICE DEFECTIVE 11 0.0006
66 LOSS OF THERAPEUTIC RESPONSE 2 0.0006
67 INCORRECT DOSE ADMINISTERED BY PRODUCT 1 0.0006
68 DENTAL IMPLANTATION 1 0.0006
69 SHOULDER FRACTURE 1 0.0006
70 SERUM FERRITIN DECREASED 1 0.0006
71 TREATMENT DELAYED 1 0.0006
72 TYPE I HYPERSENSITIVITY 2 0.0006
73 INJECTION SITE CELLULITIS 1 0.0005
74 JOINT NOISE 1 0.0005
75 INTRACRANIAL ANEURYSM 2 0.0005
76 TRIGGER FINGER 2 0.0005
77 TONGUE BITING 1 0.0005
78 CAPILLARY LEAK SYNDROME 1 0.0005
79 SKIN INDURATION 1 0.0005
80 HEPATIC CYTOLYSIS 6 0.0005
81 HORDEOLUM 2 0.0005
82 SUSPECTED OFF LABEL USE 2 0.0004
83 KOUNIS SYNDROME 1 0.0004
84 NEUROLOGICAL DECOMPENSATION 1 0.0004
85 HYPERTRANSAMINASAEMIA 3 0.0004
86 AGRANULOCYTOSIS 8 0.0004
87 PATELLA FRACTURE 1 0.0004
88 RASH VESICULAR 2 0.0004
89 INJECTION SITE INFLAMMATION 2 0.0004
90 PRODUCT SUBSTITUTION ISSUE 23 0.0004
91 ANAPHYLACTIC REACTION 22 0.0004
92 RETINAL ARTERY OCCLUSION 1 0.0004
93 LACTOSE INTOLERANCE 1 0.0004
94 EAR DISCOMFORT 4 0.0004
95 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
96 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
97 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
98 YAWNING 1 0.0004
99 LIP BLISTER 1 0.0004
100 GASTRIC ULCER HAEMORRHAGE 2 0.0004
101 TUMOUR HAEMORRHAGE 1 0.0004
102 RETINAL VEIN OCCLUSION 1 0.0003
103 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
104 ATYPICAL PNEUMONIA 1 0.0003
105 THYROIDITIS 1 0.0003
106 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
107 PLATELET COUNT ABNORMAL 2 0.0003
108 BURSITIS 4 0.0003
109 KERATITIS 1 0.0003
110 INJECTION SITE HYPERSENSITIVITY 1 0.0003
111 INJECTION SITE INFECTION 1 0.0003
112 COLITIS ISCHAEMIC 2 0.0003
113 TONGUE ULCERATION 1 0.0003
114 HEPATIC FIBROSIS 1 0.0003
115 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
116 JAUNDICE CHOLESTATIC 1 0.0003
117 PANIC REACTION 2 0.0003
118 RHEUMATOID ARTHRITIS 31 0.0003
119 PARADOXICAL DRUG REACTION 1 0.0003
120 TONGUE OEDEMA 1 0.0003
121 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
122 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
123 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
124 RHINOVIRUS INFECTION 1 0.0003
125 PELVIC FRACTURE 2 0.0003
126 EPIGASTRIC DISCOMFORT 1 0.0003
127 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
128 ORGAN FAILURE 1 0.0002
129 LIP OEDEMA 1 0.0002
130 MUSCLE FATIGUE 1 0.0002
131 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
132 POOR PERIPHERAL CIRCULATION 1 0.0002
133 PURULENT DISCHARGE 1 0.0002
134 METASTATIC NEOPLASM 1 0.0002
135 IMMOBILE 1 0.0002
136 PRODUCT COMMUNICATION ISSUE 2 0.0002
137 ILEUS PARALYTIC 1 0.0002
138 LUMBAR VERTEBRAL FRACTURE 1 0.0002
139 SYNOVIAL CYST 1 0.0002
140 URTICARIA 36 0.0002
141 TIBIA FRACTURE 1 0.0002
142 SPINAL DISORDER 2 0.0002
143 INTENTIONAL DOSE OMISSION 6 0.0002
144 BRONCHOSPASM 3 0.0002
145 HYPOVOLAEMIC SHOCK 1 0.0002
146 INJECTION SITE URTICARIA 5 0.0002
147 HYPERVOLAEMIA 1 0.0002
148 INFLAMMATORY MARKER INCREASED 1 0.0002
149 ANEURYSM 1 0.0002
150 HEPATIC ENZYME ABNORMAL 1 0.0002
151 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
152 TOE AMPUTATION 1 0.0002
153 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
154 INITIAL INSOMNIA 2 0.0002
155 INJECTION SITE WARMTH 4 0.0002
156 ANAPHYLACTIC SHOCK 5 0.0002
157 FOETAL DEATH 1 0.0002
158 FAILURE TO THRIVE 1 0.0002
159 INJECTION SITE DISCHARGE 1 0.0002
160 HIP SURGERY 1 0.0002
161 BIPOLAR DISORDER 2 0.0002
162 NEOPLASM 2 0.0002
163 HERPES VIRUS INFECTION 1 0.0002
164 MOUTH SWELLING 1 0.0002
165 HYPERTRIGLYCERIDAEMIA 1 0.0002
166 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
167 THERAPY INTERRUPTED 12 0.0002
168 TYPE 1 DIABETES MELLITUS 1 0.0002
169 INGUINAL HERNIA 1 0.0002
170 VULVOVAGINAL BURNING SENSATION 1 0.0002
171 INJECTION SITE RASH 5 0.0002
172 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
173 INJECTION SITE REACTION 11 0.0002
174 INJECTION SITE INDURATION 2 0.0002
175 HEPATITIS ACUTE 1 0.0002
176 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
177 TENDON DISORDER 1 0.0002
178 CYTOKINE RELEASE SYNDROME 3 0.0001
179 UVEITIS 2 0.0001
180 DEVICE MECHANICAL ISSUE 2 0.0001
181 ECCHYMOSIS 1 0.0001
182 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
183 ONYCHOCLASIS 1 0.0001
184 DROOLING 1 0.0001
185 LARGE INTESTINE PERFORATION 1 0.0001
186 LUNG DISORDER 7 0.0001
187 DEFAECATION URGENCY 1 0.0001
188 PULMONARY TOXICITY 1 0.0001
189 JOINT SWELLING 17 0.0001
190 PARALYSIS 2 0.0001
191 VISUAL FIELD DEFECT 1 0.0001
192 SWELLING FACE 9 0.0001
193 INFLAMMATION 7 0.0001
194 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
195 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
196 TRANSAMINASES INCREASED 3 0.0001
197 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
198 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
199 HYPOAESTHESIA ORAL 2 0.0001
200 PEMPHIGOID 1 0.0001
201 LIPASE INCREASED 1 0.0001
202 SHOCK 3 0.0001
203 PROCEDURAL COMPLICATION 1 0.0001
204 BRAIN FOG 2 0.0001
205 HYPOTHYROIDISM 4 0.0001
206 HIP FRACTURE 4 0.0001
207 PERIPHERAL SWELLING 19 0.0001
208 SHOCK HAEMORRHAGIC 1 0.0001
209 EOSINOPHIL COUNT INCREASED 1 0.0001
210 INJECTION SITE PRURITUS 8 0.0001
211 OSTEOARTHRITIS 5 0.0001
212 SWELLING 11 0.0001
213 SCAR 2 0.0001
214 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
215 DEAFNESS 3 0.0001
216 JOINT STIFFNESS 3 0.0001
217 GRIP STRENGTH DECREASED 1 0.0001
218 IMMUNOSUPPRESSION 1 0.0001
219 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
220 SYNOVITIS 2 0.0001
221 PELVIC PAIN 2 0.0001
222 INJECTION SITE MASS 4 0.0001
223 PRODUCT DISTRIBUTION ISSUE 1 0.0001
224 OXYGEN SATURATION DECREASED 6 0.0001
225 HEPATIC CIRRHOSIS 2 0.0001
226 INJECTION SITE ERYTHEMA 13 0.0001
227 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
228 PULMONARY FIBROSIS 2 0.0001
229 CHOLESTASIS 2 0.0001
230 LOWER LIMB FRACTURE 2 0.0001
231 ORAL HERPES 2 0.0001
232 VITREOUS FLOATERS 1 0.0001
233 RESPIRATORY DISORDER 3 0.0001
234 EMPHYSEMA 1 0.0001
235 PRURITUS 38 0.0001
236 TOOTH ABSCESS 1 0.0001
237 HYPERSENSITIVITY 18 0.0001
238 HYPERBILIRUBINAEMIA 1 0.0001
239 ARTHRALGIA 40 0.0001
240 KNEE ARTHROPLASTY 2 0.0001
241 FULL BLOOD COUNT ABNORMAL 1 0.0001
242 CHILLS 11 0.0001
243 NIGHT SWEATS 3 0.0001
244 INJECTION SITE SWELLING 7 0.0001
245 MELAENA 2 0.0001
246 ANGIOEDEMA 4 0.0001
247 FOOT DEFORMITY 1 0.0001
248 VENTRICULAR FIBRILLATION 1 0.0001
249 INTESTINAL PERFORATION 1 0.0001
250 EYE INFECTION 1 0.0001
251 HEART RATE IRREGULAR 2 0.0001
252 SCAB 1 0.0001
253 ELECTROLYTE IMBALANCE 1 0.0001
254 EYELID OEDEMA 1 0.0001
255 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
256 SPINAL PAIN 1 0.0001
257 HYPOXIA 3 0.0001
258 MUSCLE RIGIDITY 1 0.0001
259 WRIST FRACTURE 1 0.0001
260 CYTOPENIA 1 0.0001
261 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
262 SMALL INTESTINAL OBSTRUCTION 1 0.0001
263 DERMATITIS ALLERGIC 1 0.0001
264 HEPATITIS 2 0.0001
265 THERAPY CESSATION 4 0.0001
266 INFUSION SITE PAIN 1 0.0001
267 ORAL CANDIDIASIS 1 0.0001
268 IMMUNE SYSTEM DISORDER 1 0.0001
269 BRADYCARDIA 4 0.0001
270 QUALITY OF LIFE DECREASED 1 0.0001
271 THROAT TIGHTNESS 2 0.0001
272 LIMB INJURY 2 0.0001
273 HEPATIC ENZYME INCREASED 5 0.0001
274 SKIN LESION 2 0.0001
275 PERIPHERAL COLDNESS 1 0.0001
276 ORAL DISCOMFORT 1 0.0001
277 MASS 1 0.0001
278 CARPAL TUNNEL SYNDROME 1 0.0001
279 BLOOD TEST ABNORMAL 1 0.0001
280 SKIN REACTION 1 0.0001
281 ANGINA PECTORIS 2 0.0001
282 HYPOKINESIA 1 0.0001
283 LIVER FUNCTION TEST ABNORMAL 2 0.0001
284 MUSCULOSKELETAL STIFFNESS 6 0.0001
285 URINARY INCONTINENCE 2 0.0001
286 PULMONARY MASS 1 0.0001
287 THERAPY NON-RESPONDER 3 0.0001
288 STOMATITIS 4 0.0001
289 DISCOMFORT 4 0.0001
290 INSURANCE ISSUE 1 0.0001
291 HEADACHE 41 0.0001
292 HIP ARTHROPLASTY 1 0.0001
293 FEELING HOT 4 0.0001
294 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
295 ANKLE FRACTURE 1 0.0001
296 FEMUR FRACTURE 2 0.0001
297 RASH 28 0.0001
298 CYANOSIS 1 0.0001
299 ARTHRITIS 5 0.0001
300 PAIN 39 0.0001
301 ERYTHEMA 13 0.0001
302 ULCER 1 0.0001
303 RASH ERYTHEMATOUS 3 0.0001
304 INJECTION SITE HAEMORRHAGE 5 0.0001
305 BLOOD POTASSIUM INCREASED 1 0.0001
306 HYPOAESTHESIA 9 0.0001
307 DRY EYE 3 0.0001
308 LIP SWELLING 2 0.0001
309 COAGULOPATHY 1 0.0001
310 GAIT INABILITY 2 0.0001
311 EYE PRURITUS 2 0.0001
312 PERICARDITIS 1 0.0001
313 FACE OEDEMA 1 0.0001
314 CANDIDA INFECTION 1 0.0001
315 HAEMATURIA 2 0.0001
316 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
317 PAIN IN EXTREMITY 17 0.0001
318 ORTHOSTATIC HYPOTENSION 1 0.0001
319 SYRINGE ISSUE 1 0.0001
320 EOSINOPHILIA 1 0.0001
321 COLD SWEAT 1 0.0001
322 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
323 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
324 DRUG ERUPTION 1 0.0001
325 CEREBRAL HAEMORRHAGE 2 0.0001
326 GASTROINTESTINAL DISORDER 5 0.0001
327 GOUT 1 0.0001
328 MYELOSUPPRESSION 2 0.0001
329 RASH PRURITIC 3 0.0001
330 OEDEMA 3 0.0001
331 TOOTHACHE 1 0.0001
332 C-REACTIVE PROTEIN INCREASED 2 0.0001
333 HEPATIC STEATOSIS 1 0.0001
334 THROMBOCYTOPENIA 6 0.0001
335 BLISTER 3 0.0001
336 PHOTOPHOBIA 1 0.0001
337 MUSCULAR WEAKNESS 6 0.0001
338 COLITIS 2 0.0001
339 GASTRIC ULCER 1 0.0001
340 PROTEINURIA 1 0.0001
341 EYE IRRITATION 3 0.0001
342 HERNIA 1 0.0001
343 HAEMORRHOIDS 1 0.0001
344 NASAL CONGESTION 3 0.0001
345 KIDNEY INFECTION 1 0.0001
346 HAEMATOCRIT DECREASED 1 0.0001
347 BLOOD PRESSURE ABNORMAL 1 0.0001
348 UPPER LIMB FRACTURE 1 0.0001
349 PREGNANCY 1 0.0000
350 PNEUMONIA 16 0.0000
351 CONDITION AGGRAVATED 15 0.0000
352 DRY MOUTH 4 0.0000
353 VERTIGO 3 0.0000
354 BONE MARROW FAILURE 1 0.0000
355 NEUTROPHIL COUNT DECREASED 2 0.0000
356 CHEST DISCOMFORT 5 0.0000
357 ILLNESS 5 0.0000
358 PERITONITIS 1 0.0000
359 TOOTH LOSS 1 0.0000
360 POLLAKIURIA 2 0.0000
361 MOUTH ULCERATION 1 0.0000
362 EATING DISORDER 1 0.0000
363 IMPAIRED WORK ABILITY 1 0.0000
364 HYPERHIDROSIS 6 0.0000
365 RECTAL HAEMORRHAGE 2 0.0000
366 SKIN CANCER 1 0.0000
367 RHINORRHOEA 3 0.0000
368 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
369 PRODUCT DISPENSING ERROR 1 0.0000
370 INFUSION RELATED REACTION 3 0.0000
371 RASH PAPULAR 1 0.0000
372 SNEEZING 1 0.0000
373 NEUTROPENIA 6 0.0000
374 PRODUCT AVAILABILITY ISSUE 1 0.0000
375 NEPHROLITHIASIS 2 0.0000
376 TINNITUS 2 0.0000
377 SKIN DISCOLOURATION 2 0.0000
378 BLOOD CHOLESTEROL INCREASED 2 0.0000
379 COUGH 12 0.0000
380 DEVICE MALFUNCTION 3 0.0000
381 TREMOR 7 0.0000
382 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
383 MIGRAINE 4 0.0000
384 MENTAL IMPAIRMENT 1 0.0000
385 RESPIRATORY FAILURE 3 0.0000
386 PRESYNCOPE 1 0.0000
387 PRODUCT DOSE OMISSION ISSUE 12 0.0000
388 EPISTAXIS 3 0.0000
389 CELLULITIS 2 0.0000
390 ACNE 3 0.0000
391 ABDOMINAL PAIN LOWER 1 0.0000
392 CARDIOVASCULAR DISORDER 1 0.0000
393 DRUG RESISTANCE 1 0.0000
394 SKIN ULCER 1 0.0000
395 NO ADVERSE EVENT 7 0.0000
396 HAEMATOMA 1 0.0000
397 EXPOSURE VIA SKIN CONTACT 1 0.0000
398 MENSTRUATION IRREGULAR 1 0.0000
399 BLOOD BILIRUBIN INCREASED 1 0.0000
400 PNEUMONITIS 1 0.0000
401 DIVERTICULITIS 1 0.0000
402 PROCEDURAL PAIN 1 0.0000
403 ARTHROPATHY 2 0.0000
404 SEPSIS 4 0.0000
405 PANCYTOPENIA 2 0.0000
406 SKIN EXFOLIATION 3 0.0000
407 TARDIVE DYSKINESIA 1 0.0000
408 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
409 PAIN IN JAW 1 0.0000
410 RED BLOOD CELL COUNT DECREASED 1 0.0000
411 HYPOTENSION 7 0.0000
412 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
413 FATIGUE 27 0.0000
414 INFECTION 5 0.0000
415 DYSSTASIA 1 0.0000
416 PALPITATIONS 4 0.0000
417 SURGERY 2 0.0000
418 LABORATORY TEST ABNORMAL 1 0.0000
419 PSYCHOTIC DISORDER 1 0.0000
420 WHEEZING 2 0.0000
421 APHASIA 1 0.0000
422 HYPERTENSION 7 0.0000
423 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
424 OROPHARYNGEAL PAIN 3 0.0000
425 CHEST PAIN 6 0.0000
426 DRUG INEFFECTIVE 42 0.0000
427 PARAESTHESIA 5 0.0000
428 METABOLIC ACIDOSIS 1 0.0000
429 MOVEMENT DISORDER 1 0.0000
430 DRUG INTOLERANCE 3 0.0000
431 STAPHYLOCOCCAL INFECTION 1 0.0000
432 HEART RATE INCREASED 3 0.0000
433 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
434 DIZZINESS 15 0.0000
435 VIRAL INFECTION 1 0.0000
436 DYSPNOEA 17 0.0000
437 FUNGAL INFECTION 1 0.0000
438 SYNCOPE 3 0.0000
439 SKIN DISORDER 1 0.0000
440 VOMITING 14 0.0000
441 MYALGIA 5 0.0000
442 DEATH 25 0.0000
443 ABDOMINAL DISTENSION 3 0.0000
444 BURNING SENSATION 2 0.0000
445 HEART RATE DECREASED 1 0.0000
446 INJURY 2 0.0000
447 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
448 DIARRHOEA 18 0.0000
449 CRYING 1 0.0000
450 INFLUENZA 3 0.0000
451 EYE SWELLING 1 0.0000
452 HALLUCINATION 2 0.0000
453 GAIT DISTURBANCE 5 0.0000
454 HOSPITALISATION 4 0.0000
455 PYREXIA 9 0.0000
456 SEIZURE 3 0.0000
457 DISORIENTATION 1 0.0000
458 MALAISE 11 0.0000
459 EXTRA DOSE ADMINISTERED 1 0.0000
460 OSTEOPOROSIS 1 0.0000
461 VISUAL IMPAIRMENT 3 0.0000
462 LOSS OF CONSCIOUSNESS 3 0.0000
463 BALANCE DISORDER 2 0.0000
464 SEPTIC SHOCK 1 0.0000
465 MENTAL DISORDER 1 0.0000
466 CONSTIPATION 5 0.0000
467 INTENTIONAL PRODUCT MISUSE 2 0.0000
468 OFF LABEL USE 20 0.0000
469 INJECTION SITE PAIN 7 0.0000
470 NAUSEA 18 0.0000
471 TACHYCARDIA 2 0.0000
472 PULMONARY OEDEMA 1 0.0000
473 DEVICE ISSUE 2 0.0000
474 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
475 THROAT IRRITATION 1 0.0000
476 ADVERSE DRUG REACTION 2 0.0000
477 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
478 ASTHENIA 8 0.0000
479 ARRHYTHMIA 1 0.0000
480 DYSPHAGIA 2 0.0000
481 PULMONARY EMBOLISM 2 0.0000
482 FALL 7 0.0000
483 NEUROPATHY PERIPHERAL 2 0.0000
484 CONTUSION 2 0.0000
485 INTERSTITIAL LUNG DISEASE 1 0.0000
486 ATRIAL FIBRILLATION 2 0.0000
487 ALOPECIA 4 0.0000
488 DYSPEPSIA 2 0.0000
489 LEUKOPENIA 1 0.0000
490 SOMNOLENCE 4 0.0000
491 BLOOD PRESSURE INCREASED 3 0.0000
492 SINUSITIS 2 0.0000
493 ABDOMINAL PAIN UPPER 4 0.0000
494 PANCREATITIS 1 0.0000
495 WEIGHT DECREASED 5 0.0000
496 NECK PAIN 1 0.0000
497 ABDOMINAL DISCOMFORT 3 0.0000
498 WEIGHT INCREASED 4 0.0000
499 EYE PAIN 1 0.0000
500 HERPES ZOSTER 1 0.0000
501 DECREASED APPETITE 4 0.0000
502 ABDOMINAL PAIN 4 0.0000
503 THERAPEUTIC RESPONSE DECREASED 1 0.0000
504 ILL-DEFINED DISORDER 1 0.0000
505 MUSCLE SPASMS 3 0.0000
506 DEEP VEIN THROMBOSIS 1 0.0000
507 DEVICE DIFFICULT TO USE 1 0.0000
508 RENAL FAILURE 2 0.0000
509 VISION BLURRED 2 0.0000
510 SKIN BURNING SENSATION 1 0.0000
511 AGITATION 1 0.0000
512 BRONCHITIS 1 0.0000
513 DYSGEUSIA 1 0.0000
514 HOT FLUSH 1 0.0000
515 ACUTE KIDNEY INJURY 2 0.0000
516 FEELING ABNORMAL 3 0.0000
517 PROSTATE CANCER 1 0.0000
518 INFLUENZA LIKE ILLNESS 1 0.0000
519 TREATMENT FAILURE 1 0.0000
520 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
521 CEREBROVASCULAR ACCIDENT 2 0.0000
522 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
523 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
524 NASOPHARYNGITIS 2 0.0000
525 CARDIAC DISORDER 1 0.0000
526 FLUSHING 1 0.0000
527 HAEMOGLOBIN DECREASED 1 0.0000
528 PLATELET COUNT DECREASED 1 0.0000
529 OVERDOSE 2 0.0000
530 INCORRECT DOSE ADMINISTERED 2 0.0000
531 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
532 INSOMNIA 2 0.0000
533 DRUG INTERACTION 1 0.0000
534 URINARY TRACT INFECTION 1 0.0000
535 MYOCARDIAL INFARCTION 1 0.0000
536 COVID-19 1 0.0000
537 PRODUCT USE ISSUE 1 0.0000
538 BLOOD GLUCOSE INCREASED 1 0.0000
539 ANAEMIA 1 0.0000
540 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
541 DEPRESSION 1 0.0000
542 BACK PAIN 1 0.0000